Study of the Impact of Digital Health Interventions on Symptom & Side-Effect Management in Metastatic Sarcoma Patients
Observational, Randomized, Prospective Study of the Impact of Digital Health Interventions on Symptom and Side-Effect Management in Patients With Metastatic Sarcoma
CareAcross
108 participants
Aug 22, 2023
INTERVENTIONAL
Conditions
Summary
The objective of this prospective study is to capture the quality of life of patients with locally advanced or metastatic sarcoma, and investigate the effectiveness of support provided through a personalized web-based platform.
Eligibility
Inclusion Criteria5
- Age of ≥ 18 years.
- Diagnosis of locally advanced or metastatic sarcoma of any location and origin.
- Ability to understand and operate in a digital environment.
- Patients planned to start standard of care treatment within the next month, or are currently undergoing standard of care treatment of any line.
- Treatments include surgery, radiotherapy, chemotherapy, immunotherapy, targeted therapy, hormonal therapy, or any combination of the above.
Exclusion Criteria4
- Limited ability or willingness to report side-effects on an online platform.
- Performance status >3.
- Life expectancy of <6 months.
- Participation in an interventional clinical trial with investigational drugs or devices.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Personalized educational and supportive material, based on each patients' adverse events reported as PROs, delivered via the online platform.
Locations(11)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07642375